Wednesday, September 17, 2014   

France busts record 2.4m doses of dodgy China drugs
(04-10 18:56)

French customs have confiscated millions of counterfeit drugs from China in what they described as the biggest seizure in the European Union.
A total of 2.4 million doses of drugs for ailments including diarrhea, headaches and erectile dysfunction were seized at the end of February in the port of Le Havre in boxes labelled as containing Chinese tea, customs officials said today.
“Some of the drugs contain no active ingredient, which constitutes outright cheating of consumers,'' a statement from the customs executive said.
“Others have different levels of the active ingredient compared to the authentic drug which means they could represent a serious health risk for patients taking them.''
According to French customs, the previous record seizure in the EU was for 1.2 million doses of counterfeit aspirin, also made at Le Havre in Normandy, in May 2013.—AFP
   
Other World breaking news:
Japan wants North Korea abductions report soon (2 hrs 32 mins ago)
Spain PM warns independence votes 'torpedo' EU (2 hrs 41 mins ago)
Kosovo arrests 15 over promoting radical Islam (2 hrs 44 mins ago)
King of Sweden escapes unhurt in Stockholm car accident (09-17 18:23)
Thailand conducts autopsies on slain Britons (09-17 17:54)
SKorea, US to hold nuclear energy talks (09-17 17:12)
Senior diplomats from SKorea, Japan to meet in Tokyo for talks (09-17 16:32)
'Modern slavery' in Malaysia electronics factories: study (09-17 16:21)
Quake strikes off Guam (09-17 15:10)
Bangladesh court commutes top Islamist's death sentence (09-17 13:08)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.